![](https://www.diabetesnews.com/wp-content/uploads/2012/09/7661-150x147.png)
Philadelphia-based Echo Therapeutics plans to introduce a needle-free continuous glucose monitoring system to the US market in 2013, pending FDA approval.
Read more
Philadelphia-based Echo Therapeutics plans to introduce a needle-free continuous glucose monitoring system to the US market in 2013, pending FDA approval.
Read more